Galera Therapeutics Inc Ordinary Shares Analyst Price Targets - Benzinga

Galera Therapeutics Inc Ordinary Shares

GRTXOTC

Trade with Public

Trade with Public

$0.1450

-42.88-99.66%

At close: May 31, 5:00 PM EST

$0.0840

-42.94-99.8%

Pre-Market: Jul 10, 5:00 PM EST

Overview News Earnings Forecast Financials Sentiment Ownership Compare

Galera Therapeutics Inc Ordinary Shares Analyst Price Targets

Wall Street analyst price targets and consensus rating for Galera Therapeutics Inc Ordinary Shares (GRTX).

Analyst Ratings News

Expert Ratings for Galera Therapeutics

Benzinga Insights

Citigroup Maintains Neutral Rating for Galera Therapeutics: Here's What You Need To Know

Benzinga Insights

PRO
Citigroup Maintains Neutral on Galera Therapeutics, Lowers Price Target to $0.25

Citigroup analyst Yigal Nochomovitz maintains Galera Therapeutics (NASDAQ:GRTX) with a Neutral and lowers the price target from $0.4 to $0.25.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023

Benzinga Insights

PRO
HC Wainwright & Co. Downgrades Galera Therapeutics to Neutral, Lowers Price Target to $0.3

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Galera Therapeutics (NASDAQ:GRTX) from Buy to Neutral and lowers the price target from $6 to $0.3.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023

Benzinga Insights